{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T09:22:42Z","timestamp":1768641762843,"version":"3.49.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1745-6215-10-109","type":"journal-article","created":{"date-parts":[[2009,12,8]],"date-time":"2009-12-08T10:40:27Z","timestamp":1260268827000},"source":"Crossref","is-referenced-by-count":50,"title":["The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury"],"prefix":"10.1186","volume":"10","author":[{"given":"Haleema","family":"Shakur","sequence":"first","affiliation":[]},{"given":"Peter","family":"Andrews","sequence":"additional","affiliation":[]},{"given":"Toomas","family":"Asser","sequence":"additional","affiliation":[]},{"given":"Laura","family":"Balica","sequence":"additional","affiliation":[]},{"given":"Cristian","family":"Boeriu","sequence":"additional","affiliation":[]},{"given":"Juan Diego Ciro","family":"Quintero","sequence":"additional","affiliation":[]},{"given":"Yashbir","family":"Dewan","sequence":"additional","affiliation":[]},{"given":"Patrick","family":"Druw\u00e9","sequence":"additional","affiliation":[]},{"given":"Olivia","family":"Fletcher","sequence":"additional","affiliation":[]},{"given":"Chris","family":"Frost","sequence":"additional","affiliation":[]},{"given":"Bennie","family":"Hartzenberg","sequence":"additional","affiliation":[]},{"given":"Jorge Mejia","family":"Mantilla","sequence":"additional","affiliation":[]},{"given":"Francisco","family":"Murillo-Cabezas","sequence":"additional","affiliation":[]},{"given":"Jan","family":"Pachl","sequence":"additional","affiliation":[]},{"given":"Ramalingam R","family":"Ravi","sequence":"additional","affiliation":[]},{"given":"Indrek","family":"R\u00e4tsep","sequence":"additional","affiliation":[]},{"given":"Cristina","family":"Sampaio","sequence":"additional","affiliation":[]},{"given":"Manmohan","family":"Singh","sequence":"additional","affiliation":[]},{"given":"Petr","family":"Svoboda","sequence":"additional","affiliation":[]},{"given":"Ian","family":"Roberts","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2009,12,3]]},"reference":[{"issue":"2","key":"397_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3171\/jns.2000.93.2.0183","volume":"93","author":"A Marmarou","year":"2000","unstructured":"Marmarou A, Fatouros PP, Barz\u00f3 P, Portella G, Yoshihara M, Tsuji O, Yamamoto T, Laine F, Signoretti S, Ward JD, Bullock MR, Young HF: Contribution of edema and cerebral blood volume to traumatic brain swelling in head-injured patients. J Neurosurg. 2000, 93 (2): 183-93. 10.3171\/jns.2000.93.2.0183. Erratum in: J Neurosurg 2001, 94(2):349","journal-title":"J Neurosurg"},{"key":"397_CR2","first-page":"S69","volume":"59","author":"L Schilling","year":"1997","unstructured":"Schilling L, Wahl M: Brain edema: pathogenesis and therapy. Kidney Int Suppl. 1997, 59: S69-75.","journal-title":"Kidney Int Suppl"},{"issue":"1-3","key":"397_CR3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0162-3109(96)00068-9","volume":"33","author":"M Wahl","year":"1996","unstructured":"Wahl M, Whalley ET, Unterberg A, Schilling L, Parsons AA, Baethmann A, Young AR: Vasomotor and permeability effects of bradykinin in the cerebral microcirculation. Immunopharmacology. 1996, 33 (1-3): 257-63. 10.1016\/0162-3109(96)00068-9.","journal-title":"Immunopharmacology"},{"issue":"12","key":"397_CR4","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1089\/neu.2005.22.1444","volume":"22","author":"A Marmarou","year":"2005","unstructured":"Marmarou A, Guy M, Murphey L, Roy F, Layani L, Combal JP: A single dose, three-arm, placebo-controlled, phase I study of the bradykinin B2 receptor antagonist Anatibant (LF16-0687Ms) in patients with severe traumatic brain injury. Journal of Neurotrauma. 2005, 22 (12): 1444-55. 10.1089\/neu.2005.22.1444.","journal-title":"Journal of Neurotrauma"},{"key":"397_CR5","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1201\/b13492-24","volume-title":"Neuroprotection in traumatic brain injury. IN: Head Injury - Pathophysiology and Management","author":"A IR Maas","year":"2005","unstructured":"Maas A, Schouten J, Teasdale G: Neuroprotection in traumatic brain injury. IN: Head Injury - Pathophysiology and Management. Edited by: Reilly PL, Bullock R. 2005, Hodder Arnold: London, UK, 406-440. ISBN: 0340-80724-5, 2","edition":"2"},{"issue":"1","key":"397_CR6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1755-5949.2008.00069.x","volume":"15","author":"K Ker","year":"2009","unstructured":"Ker K, Perel P, Blackhall K: Beta-2 receptor antagonists for traumatic brain injury: a systematic review of controlled trials in animal models. CNS Neuroscience & Therapeutics. 2009, 15 (1): 52-64.","journal-title":"CNS Neuroscience & Therapeutics"},{"key":"397_CR7","doi-asserted-by":"crossref","unstructured":"Ker K, Blackhall K: Beta-2 receptor antagonists for acute traumatic brain injury. Cochrane Database of Systematic Reviews. 2008, 10.1002\/14651858.CD006686.pub2. 1","DOI":"10.1002\/14651858.CD006686.pub2"},{"issue":"1-2","key":"397_CR8","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S0006-8993(02)03053-6","volume":"20;950","author":"S Zausinger","year":"2002","unstructured":"Zausinger S, Lumenta DB, Pruneau D, Schmid-Elsaesser R, Plesnila N, Baethmann A: Effects of LF 16-0687 Ms, a bradykinin B(2) receptor antagonist, on brain edema formation and tissue damage in a rat model of temporary focal cerebral ischemia. Brain Res. 2002, 20;950 (1-2): 268-78. 10.1016\/S0006-8993(02)03053-6.","journal-title":"Brain Res"},{"issue":"8","key":"397_CR9","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1089\/089771502320317104","volume":"19","author":"J Kaplanski","year":"2002","unstructured":"Kaplanski J, Pruneau D, Asa I, Artru AA, Azez A, Ivashkova Y, Rudich Z, Shapira Y: LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces brain edema and improves long-term neurological function recovery after closed head trauma in rats. J Neurotrauma. 2002, 19 (8): 953-64. 10.1089\/089771502320317104.","journal-title":"J Neurotrauma"},{"key":"397_CR10","first-page":"205","volume":"86","author":"S Zausinger","year":"2003","unstructured":"Zausinger S, Lumenta DB, Pruneau D, Schmid-Elsaesser R, Plesnila N, Baethmann A: Therapeutic efficacy of a novel non-peptide bradykinin B2 receptor antagonist on brain edema formation and ischemic tissue damage in focal cerebral ischemia. Acta Neurochir Suppl. 2003, 86: 205-7.","journal-title":"Acta Neurochir Suppl"},{"issue":"8","key":"397_CR11","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1038\/sj.bjp.0705385","volume":"139","author":"L Ding-Zhou","year":"2003","unstructured":"Ding-Zhou L, Margaill I, Palmier B Pruneau D, Plotkine M, Marchand-Verecchia C: LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces ischemic brain injury in a murine model of transtient focal cerebral ischemia. Br J Pharmacol. 2003, 139 (8): 1539-47. 10.1038\/sj.bjp.0705385.","journal-title":"Br J Pharmacol"},{"key":"397_CR12","unstructured":"XY2405, Bradykinin B2 Receptor Antagonist, INVESTIGATOR'S BROCHURE, VERSION 2.0, Release Date: 10 August 2006 (Xytis Pharmaceuticals)."},{"key":"397_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-4541-9","volume-title":"An introduction to the Bootstrap","author":"B Efron","year":"1993","unstructured":"Efron B, Tibshirani RJ: An introduction to the Bootstrap. 1993, Chapman and Hall\/CRC"},{"key":"397_CR14","unstructured":"ICH Harmonised Tripartite Guideline for Good Clinical Practice. 1996, \n                    http:\/\/www.ich.org\/LOB\/media\/MEDIA482.pdf"},{"issue":"9","key":"397_CR15","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1503\/cmaj.071366","volume":"178","author":"D Cook","year":"2008","unstructured":"Cook D, Lauzier F, Rocha M M, Sayles MJ, Finfer S: Serious adverse events in academic critical care research. CMAJ. 2008, 178 (9): 1181-1184.","journal-title":"CMAJ"},{"issue":"10","key":"397_CR16","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1097\/01.CCM.0000181729.46010.83","volume":"33","author":"J-L Vincent","year":"2005","unstructured":"Vincent J-L, for the ENHANCE Study Group: Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment. Crit Care Med. 2005, 33 (10): 2266-2277. 10.1097\/01.CCM.0000181729.46010.83.","journal-title":"Crit Care Med"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1745-6215-10-109\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-10-109.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-10-109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-10-109.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T13:57:38Z","timestamp":1548165458000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1745-6215-10-109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["397"],"URL":"https:\/\/doi.org\/10.1186\/1745-6215-10-109","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12]]},"article-number":"109"}}